'An excellent outcome': TAVR safe and effective for patients in their nineties
New data in *The American Journal of Cardiology* shows TAVR is safe and effective for nonagenarians, with a 30-day mortality rate of 5.5% and 1-year mortality of 11.6%, suggesting fast recovery post-TAVR.
Reference News
'An excellent outcome': TAVR safe and effective for patients in their nineties
New data in *The American Journal of Cardiology* shows TAVR is safe and effective for nonagenarians, with a 30-day mortality rate of 5.5% and 1-year mortality of 11.6%, suggesting fast recovery post-TAVR.